NON–ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI) OUTCOMES IN TYPE 2 DIABETIC PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY STENOSIS: DIABETIC MYOCARDIAL INFARCTION CORONARY NON-OBSTRUCTIVE STENOSIS: DIA-MYCONOS STUDY.

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2017, Vol 4, Issue 8

Abstract

Objective: Management of type 2 diabetic patients (DMT2) with non-obstructive coronary stenosis (NOCS) Non–ST-Elevation Myocardial Infarction (NSTEMI) is unclear. We evaluate the 12-month prognosis of DMT2 with NOCS-NSTEMI and compared them with a cohort of DMT2 with NSTEMI and obstructive coronary stenosis (OCS) treated with percutaneous coronary intervention (PCI). Methods: DIAbetic MYocardial COronary Non-Obstructive Stenosis (DIA-MYCONOS) was an observational study prospective study of NSTEMI DMT2 patients undergoing angiographic study. 1098 DMT2 patients with first NSTEMI undergoing coronary angiography were studied. Patients were categorized in two groups, either with or without OCS (stenosis >50%). OCS patients were treated with PCI and optimal medical therapy (n=922, 84%). NOCS patients were treated with optimal medical therapy alone (n=176, 16%). Endpoints included cardiac mortality, all-cause mortality and re-hospitalization for coronary disease and heart failure. Results: OCS-NSTEMI patients were undergoing to PCI plus medical therapy, whereas NOCS-NSTEMI patients were treated with medical therapy. Groups received similar secondary prevention therapies. 1098 patients were followed-up for 1 year. In-hospital mortality was similar (1.11 vs. 1.14%), and 1-year total mortality was 6.72% in NSTEMI patients with OCS treated with PCI and 11.93% in NSTEMI patients with NOCS treated with medical therapy (P<0.09). 18.3% of NSTEMI patients with OCS and 36.9% of NSTEMI patients with NOCS were re-hospitalized for cardiovascular diseases (P <0.05). Conclusions: NOCS-NSTEMI-DMT2 patients treated with medical therapy have poor prognoses as compared with OCS-NSTEMI patients treated with PCI, despite a less aggressive initial atherosclerosis. These findings evidence a possible gap in the NOCS-NSTEMI management.

Authors and Affiliations

Dr. Celestino Sardu

Keywords

Related Articles

UTILITY OF IMMUNOHISTOCHEMICAL MARKERS IN THE DIAGNOSIS OF COMMON SOFT TISSUE SARCOMAS IN ADULTS: A BRIEF REVIEW

Soft tissue sarcomas are a complex group of neoplasms arising from mesenchymal tissues. They present great difficulties for the practicing surgical pathologist due to their variety and several lines of differentiation. T...

PLASMA LONG NON-CODING RNA SNHG-18 IS A VALUABLE MARKER FOR THE SCREENING OF NON-SMALL CELL LUNG CANCER

Many research studies have proven that long non-coding RNAs (lncRNAs) may play a critical role in various cancer development and progression. However, little is known the clinical aspect of small nucleolar RNA host gene...

STRUCTURAL CHARACTERISTICS, ANTITUMOR AND ANTI-INFLAMMATORY PROPERTIES OF POLYSACCHARIDES ISOLATED FROM THE RED ALGAE TRICLEACARPA FRAGILIS GROWING ON THE LEBANESE COAST.

Objective: The purpose of this study was to extract, to determine the functional groups and to examine the anti-proliferative and the anti-inflammatory effect of the polysaccharides sulfated galactan and carrageenan extr...

PREVALENCE OF URINARY TRACT INFECTION AMONG UNIVERSITY STUDENTS CAUSED BY ESCHERICHIA COLI AND ITS SUSCEPTIBILITY TO DRUG THERAPY

Background: Urinary Tract Infection (UTI) is a very common disease encountered in medical practice and caused by bacteria, the most common is Escherichia coli (E. coli). Objectives: the main aims of the study were to sho...

EFFECT OF SHORT-TERM INSTANT COFFEE (NESCAFE) CONSUMPTION ON PLASMA TOTAL CREATINE KINASE AND WEIGHT

The effect of instantcoffee (nescafe) intake on plasma total creatine kinase (CK) and weight were examined on 30 apparently healthy persons within Port Harcourt metropolis. A total of 60 blood samples were collected (30...

Download PDF file
  • EP ID EP630461
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Dr. Celestino Sardu (2017). NON–ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI) OUTCOMES IN TYPE 2 DIABETIC PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY STENOSIS: DIABETIC MYOCARDIAL INFARCTION CORONARY NON-OBSTRUCTIVE STENOSIS: DIA-MYCONOS STUDY.. European Journal of Pharmaceutical and Medical Research, 4(8), 70-81. https://europub.co.uk/articles/-A-630461